VentriPoint Historical Cash Flow
| VPT Stock | CAD 0.11 0.01 8.33% |
Analysis of VentriPoint Diagnostics cash flow over time is an excellent tool to project VentriPoint Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 475 K or Begin Period Cash Flow of 5.4 M as it is a great indicator of VentriPoint Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining VentriPoint Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VentriPoint Diagnostics is a good buy for the upcoming year.
VentriPoint |
About VentriPoint Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in VentriPoint balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which VentriPoint's non-liquid assets can be easily converted into cash.
VentriPoint Diagnostics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from VentriPoint Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, VentriPoint Diagnostics' Investments are fairly stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Stock Based Compensation | 898.3K | 798.1K | 493.3K | 378.4K | Depreciation | 48.8K | 50.9K | 66.7K | 45.9K |
VentriPoint Diagnostics cash flow statement Correlations
Click cells to compare fundamentals
VentriPoint Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VentriPoint Diagnostics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (52.8K) | 512.3K | 8.7M | (4.1M) | (3.9M) | (3.7M) | |
| Free Cash Flow | (2.4M) | (1.1M) | (3.2M) | (4.1M) | (3.8M) | (4.0M) | |
| Change In Working Capital | 477.9K | 123.0K | (462.6K) | (331.1K) | 452.4K | 475.0K | |
| Begin Period Cash Flow | 66.6K | 13.8K | 526.0K | 9.3M | 5.2M | 5.4M | |
| Other Cashflows From Financing Activities | 1.7M | 1.1M | 3.9M | (24.5K) | (28.1K) | (26.7K) | |
| Other Non Cash Items | 276.6K | 204.4K | (26.5K) | 218.2K | 308.3K | 323.8K | |
| Total Cash From Operating Activities | (2.4M) | (1.1M) | (3.1M) | (4.1M) | (3.8M) | (4.0M) | |
| Net Income | (3.3M) | (1.9M) | (3.9M) | (4.9M) | (4.9M) | (4.6M) | |
| Total Cash From Financing Activities | 2.3M | 1.6M | 11.9M | 87.6K | (102.4K) | (97.2K) | |
| End Period Cash Flow | 13.8K | 526.0K | 9.3M | 5.2M | 1.3M | 1.5M | |
| Depreciation | 60.3K | 54.9K | 48.8K | 50.9K | 66.7K | 45.9K | |
| Stock Based Compensation | 205.1K | 394.8K | 898.3K | 798.1K | 493.3K | 378.4K | |
| Change To Inventory | 38.2K | 30.8K | 32.2K | 176.7K | 203.2K | 213.3K | |
| Total Cashflows From Investing Activities | (39.0K) | (27.4K) | (17.1K) | (3.8K) | (4.3K) | (4.5K) | |
| Change To Account Receivables | 12.6K | (97.7K) | (32.2K) | (176.7K) | 88.7K | 93.1K | |
| Change To Operating Activities | 165.4K | (51.0K) | 100.6K | 44.3K | 50.9K | 53.4K | |
| Change To Netincome | 467.6K | (1.1M) | 403.2K | 572.4K | 658.3K | 691.2K | |
| Change To Liabilities | (408.6K) | 153.8K | 326.6K | 145.6K | 131.0K | 111.7K | |
| Investments | (39.0K) | (27.4K) | (17.1K) | (3.8K) | (4.3K) | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.